Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Aspirin for Primary Prevention of CVD Remains Common in US

Todd Neale

June 24, 2024

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Daily News

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

Todd Neale

July 26, 2023

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Conference News AHA 2021

Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND

Michael O'Riordan

November 17, 2021

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

October 15, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Daily News

Coronary Calcium Scans May ID Patients Who Benefit From Aspirin

Michael O'Riordan

October 30, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

Advertisement

August 2025 Dispatch for the CV Team

Aspirin Use for Primary Prevention Declining in US: NHANES

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

November 2024 Dispatch for the CV Team

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Aspirin for Primary Prevention of CVD Remains Common in US

December 2023 Dispatch for the CV Team

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Statins Not Linked to Dementia or Memory Changes: ASPREE

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Coronary Calcium Scans May ID Patients Who Benefit From Aspirin

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content